Ladenburg Thalmann Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$6.16M	Buy	62,803 +17,710	+39%	+$2.43M	0.04%	422
2019 Q3	$5.58M	Sell	45,093 -7,567	-14%	-$1.01M	0.04%	428
2019 Q2	$7.43M	Buy	52,660 +3,928	+8%	+$542K	0.05%	346
2019 Q1	$7.36M	Buy	48,732 +19,964	+69%	+$2.87M	0.06%	330
2018 Q4	$3.61M	Buy	28,768 +4,138	+17%	+$566K	0.03%	468
2018 Q3	$3.9M	Buy	24,630 +5,538	+29%	+$838K	0.03%	466
2018 Q2	$2.53M	Hold	19,092	–	–	0.02%	603
2018 Q1	$2.53M	Buy	19,092 +1,186	+7%	+$162K	0.02%	603
2017 Q4	$2.23M	Buy	17,906 +1,698	+10%	+$210K	0.02%	637
2017 Q3	$2.01M	Sell	16,208 -208	-1%	-$24.6K	0.02%	616
2017 Q2	$1.87M	Buy	16,416 +8,749	+114%	+$941K	0.02%	617
2017 Q1	$808K	Buy	7,667 +321	+4%	+$32.2K	0.01%	1011
2016 Q4	$668K	Buy	7,346 +1,810	+33%	+$170K	0.01%	1088
2016 Q3	$553K	Sell	5,536 -1,853	-25%	-$182K	0.01%	1132
2016 Q2	$661K	Buy	7,389 +225	+3%	+$20.7K	0.01%	975
2016 Q1	$626K	Sell	7,164 -1,142	-14%	-$101K	0.01%	914
2015 Q4	$939K	Sell	8,306 -9,320	-53%	-$1M	0.02%	720
2015 Q3	$1.79M	Buy	17,626 +12,112	+220%	+$1.44M	0.04%	419
2015 Q2	$684K	Buy	5,514 +521	+10%	+$62.9K	0.01%	903
2015 Q1	$590K	Buy	4,993 +1,679	+51%	+$190K	0.01%	950
2014 Q4	$338K	Buy	3,314 +1,096	+49%	+$107K	0.01%	1120
2014 Q3	$204K	Sell	2,218 -5	-0.2%	-$434	0.01%	1213
2014 Q2	$183K	Sell	2,223 -12,846	-85%	-$982K	0.01%	1247
2014 Q1	$1.16M	Sell	15,069 -6,145	-29%	-$479K	0.03%	411
2013 Q4	$1.47M	Buy	21,214 +6,940	+49%	+$455K	0.05%	326
2013 Q3	$925K	Buy	14,274 +1,639	+13%	+$104K	0.03%	440
2013 Q2	$735K	Buy	+12,635	New	+$722K	0.03%	494

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FBT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 39% in Q4 2019, buying an estimated $2.43M and bringing the position to 62,803 shares worth $6.16M. The position accounts for 0.04% of the portfolio, ranked #422.

Ladenburg Thalmann Financial Services first reported a position in FBT in Q2 2013 and has held it in 27 quarters since. The position peaked at $7.43M in Q2 2019. 210 funds tracked by Wall St. Rank hold FBT as of Q4 2019.

Ladenburg Thalmann Financial Services held 62,803 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.16M as of Q4 2019.
Ladenburg Thalmann Financial Services bought 17,710 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2019, an estimated $2.43M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #422 holding.
Ladenburg Thalmann Financial Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 27 quarters since.
Ladenburg Thalmann Financial Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.43M in Q2 2019.
210 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.